Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VHSV G glycoprotein major determinants implicated in triggering the host type I IFN antiviral response as DNA vaccine molecular adjuvants

6 Sept 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aquaculture disease management and microbiota
Share to interferon and immune responses
Share to Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25203447
DOI: 10.1016/j.vaccine.2014.07.111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VHSV G glycoprotein major determinants implicated in triggering the host type I IFN antiviral response as DNA vaccine molecular adjuvantsPMID 25203447Read ↗

Understanding the interplay between oHSV and the host immune system: Implications for therapeutic oncolytic virus developmentSemantic proximity Read ↗

Immune imprinting and SARS-CoV-2 vaccine designSemantic proximity Read ↗

Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation VaccinesSemantic proximity Read ↗

Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in miceSemantic proximity Read ↗

Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine DesignSemantic proximity Read ↗

Vaccinomics: current findings, challenges and novel approaches for vaccine development.Semantic proximity Read ↗

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen.Semantic proximity Read ↗

Genetics and Vaccines in the Era of Personalized MedicineSemantic proximity Read ↗

Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessmentSemantic proximity Read ↗

Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responsesSemantic proximity Read ↗

Recent strategies targeting HIV glycans in vaccine designSemantic proximity Read ↗

Broadening the approaches to developing more effective vaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.